Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Hyperliquid's HYPE token surges 7% amid $90M a16z buy and a major USDC revenue deal.

Market News
19 May 2026
Blockonomi
View Source
Bullish
pluang ai news

Hyperliquid's native token HYPE gained about 7% in 24 hours, driven by a $90.87 million purchase by an a16z-linked wallet and a strategic partnership with Coinbase and Circle. This deal allows Hyperliquid to capture up to 90% of USDC reserve revenue, potentially generating $135–$160 million annually. Technical analysis shows a bullish cup-and-handle pattern suggesting a possible 55% price rise to $71–$72. Bitwise will use 10% of its BHYP ETF fees to buy HYPE, supporting token demand and buyback mechanisms. These developments position HYPE as a strong performer amid broader crypto declines and could boost Hyperliquid's ecosystem significantly.

More News

Farm Progress Show 2026 in Iowa unveils new Agronomy Zone, premium tickets, and Drone Zone for farmers

Farm Progress Show 2026 in Iowa unveils new Agronomy Zone, premium tickets, and Drone Zone for farmers

The Farm Progress Show 2026, held in Boone, Iowa from Sept. 1-3, introduces three major innovations: an expanded Agronomy Zone with research-grade crop plots and expert tours, new $60 premium ticket packages including admission, a hat, and lunch vouc...

Others
Bullish
44 minutes ago
Ormat launches Ormega100, the largest binary geothermal unit, to boost Enhanced Geothermal System deployment.

Ormat launches Ormega100, the largest binary geothermal unit, to boost Enhanced Geothermal System deployment.

Ormat Technologies introduced the Ormega100, the industry's largest binary power generation unit delivering 100 MW output, designed to accelerate commercialization and scaling of Enhanced Geothermal Systems (EGS). With 60 years of expertise and exten...

Market News
Bullish
1 hour ago
ADARx to present Phase 1/2 data on Onvuzosiran for hereditary angioedema at 2026 EAACI Congress

ADARx to present Phase 1/2 data on Onvuzosiran for hereditary angioedema at 2026 EAACI Congress

ADARx Pharmaceuticals announced it will present Phase 1/2 clinical data for Onvuzosiran, an RNA therapy for hereditary angioedema (HAE), at the 2026 EAACI Congress in Istanbul. Onvuzosiran targets plasma prekallikrein to prevent swelling attacks by r...

Market News
Bullish
1 hour ago
FDH Aero secures majority investment from Bain Capital to boost global aerospace supply chain growth

FDH Aero secures majority investment from Bain Capital to boost global aerospace supply chain growth

FDH Aero, a leading aerospace and defense supply chain provider, has agreed to a majority investment from Bain Capital Private Equity, with Audax Private Equity remaining a significant investor. This partnership aims to accelerate FDH's growth strate...

Company Fundamentals
Bullish
1 hour ago
Cyabra inks $500K+ deal to fight online hate with AI-powered disinformation detection for global research institute

Cyabra inks $500K+ deal to fight online hate with AI-powered disinformation detection for global research institute

Cyabra, an AI-driven disinformation intelligence company, has secured a contract worth over $500,000 to provide its technology to a leading international research institute focused on tracking global hate speech. The platform will help identify coord...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App